Feedback
About Management Our principles and vision Services Market research Market strategy Market access GR Regulatory Organization of events Sales & Marketing Legislation Team Contacts
Creation of a market research analytical system
Analysis of medicines and medical equipment market
Brand audit
Desk research
Competition strategy analysis in a given market segment
Launch strategy in the pharmaceutical market of Russia and CIS
Recommendations for product lifecycle management
Pricing strategies for medicines, food supplements and medical devices
Registration of medicines, food supplements and medical devices
Preparation of documents for inclusion of drugs in the EDL / ONLS lists
Monitoring and analysis of executive bodies initiatives
Monitoring of legal and other regulations
Special events: advisory boards, conferences
Organization of round tables in the regions of Russia
Holding focus groups involving opinion leaders and senior specialists
Organization of trainings for the top management
Market research
Market strategy
Market access
Communications with
the medical community

WIT Pharma is a provider of professional services for pharmaceutical companies in Russia and CIS. Our services include market research and analysis, market access and industry consulting.

Our mission:

To provide local and foreign companies the best service to help them enter and succeed in the Russian and CIS pharmaceutical markets

Completed projects:

  • Launch strategy for the drug / drug portfolio in the Russian pharmaceutical market (e.g. formation of the portfolio, analysis of the competitive environment, promotion model and sales forecast)
  • Qualitative market research for Rx medicines (e.g. the definition of disease, evaluation of existing treatment regimens, a detailed description of patient flow, etc.)
  • Analysis of the competitors' strategies in a given market segment
  • Formation of the dossier for inclusion / exclusion of products from the lists of drugs (VED, 7N, ONLS, the minimum range)
  • Carrying out data assessment on clinical and economic characteristics of the medicines by leading experts in pharmacoeconomics
  • Regular information on the latest changes in regulatory and legal regulation
Our clients
© 2026 . All rights reserved. Any violation of copyright will be prosecuted by law.